在儿科期刊中评估报告准则和试验登记:一个横截面分析
Taylor Gardner1, Todd Fernandez1, Katherine Cox1
1Department of Medical Education, Office of Medical Student Research, Oklahoma State University Center for Health Sciences, Tulsa, OK.
The Journal of pediatrics
|July 11, 2025
概括
儿科期刊往往不要求报告准则和临床试验注册,阻碍了研究质量和透明度. 加强这些政策对于提高儿科研究的科学可重复性和完整性至关重要.
科学领域:
- 医学研究 医学研究
- 期刊 出版 出版 出版 出版
- 科学完整性 科学完整性
背景情况:
- 报告准则和临床试验登记对于透明和可重复的健康研究至关重要.
- 2010年之前的评估表明,儿科期刊的采用程度各不相同.
- 确保遵守这些标准对于保持高质量的儿科科学文献至关重要.
研究的目的:
- 评估报告指南和临床试验注册要求在儿科期刊作者说明中目前的流行情况.
- 为了比较当前的采用率与2010年之前的调查结果.
- 识别对重要研究透明度工具的认可中的差距.
主要方法:
- 一项横截面研究使用Scopus数据 (2021) 分析了100个同行评审的儿科期刊的"作者说明".
- 两个独立的审查员检查了杂志的政策,提到EQUATOR网络,ICMJE,具体指南 (CONSORT,PRISMA) 和试验注册.
- 数据是在2023年12月10日收集的.
主要成果:
- 33%的期刊缺乏具体的报告指南参考; 43%没有提到临床试验注册.
- 39%的期刊引用了EQUATOR网络,68%的期刊引用了ICMJE.
- 最多引用的是CONSORT (52%) 和PRISMA (41%);大部分都缺少元分析指南 (95-99%).
结论:
- 儿科期刊显示,报告准则和临床试验注册要求的采用不足.
- 这些遗漏损害了研究质量,透明度和可重复性.
- 强制实施这些做法和探索采用障碍是儿科期刊的必要步骤.
相关概念视频
Clinical Trials
8.5K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
8.5K
Clinical Trials: Overview
4.7K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
4.7K
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
627
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
627
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
967
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
967
Pharmacokinetics in Pediatric Patients: Drug Distribution
554
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
554
Pharmacokinetics in Pediatric Patients: Drug Excretion
408
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
408


